Works by Yoshiro Nakahara

Results: 50

Small-cell lung cancer with a rare epidermal growth factor receptor gene mutation showing "wax-and-wane" transformation.

Published in:

2013

By:

Yusuke Takagi;
Yoshiro Nakahara;
Yukio Hosomi;
Tsunekazu Hishima;
Takagi, Yusuke;
Nakahara, Yoshiro;
Hosomi, Yukio;
Hishima, Tsunekazu

Publication type:

journal article

Medical management of older patients with lung cancer.

Published in:

Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1082, doi. 10.1093/jjco/hyac135

By:

Zenke, Yoshitaka;
Hakozaki, Taiki;
Nakahara, Yoshiro;
Horinouchi, Hidehito;
Ohe, Yuichiro;
(JCOG), the Lung Cancer Study Group of the Japan Clinical Oncology Group

Publication type:

Article

The role of prophylactic cranial irradiation for patients with small-cell lung cancer.

Published in:

Japanese Journal of Clinical Oncology, 2018, v. 48, n. 1, p. 26, doi. 10.1093/jjco/hyx146

By:

Yoshiro Nakahara;
Jiichiro Sasaki;
Tomoya Fukui;
Sakiko Otani;
Satoshi Igawa;
Kazushige Hayakawa;
Noriyuki Masuda

Publication type:

Article

Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors.

Published in:

Frontiers in Cell & Developmental Biology, 2024, p. 1, doi. 10.3389/fcell.2023.1324898

By:

Yoshiro Nakahara;
Taku Kouro;
Satoru Motoyama;
Masatomo Miura;
Kazuma Fujita;
Yuka Igarashi;
Naoko Higashijima;
Norikazu Matsuo;
Hidetomo Himuro;
Feifei Wei;
Shun Horaguchi;
Kayoko Tsuji;
Yasunobu Mano;
Mitsuru Komahashi;
Haruhiro Saito;
Koichi Azuma;
Tetsuro Sasada

Publication type:

Article

Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors.

Published in:

Frontiers in Cell & Developmental Biology, 2024, p. 1, doi. 10.3389/fcell.2023.1324898

By:

Yoshiro Nakahara;
Taku Kouro;
Satoru Motoyama;
Masatomo Miura;
Kazuma Fujita;
Yuka Igarashi;
Naoko Higashijima;
Norikazu Matsuo;
Hidetomo Himuro;
Feifei Wei;
Shun Horaguchi;
Kayoko Tsuji;
Yasunobu Mano;
Mitsuru Komahashi;
Haruhiro Saito;
Koichi Azuma;
Tetsuro Sasada

Publication type:

Article

Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors.

Published in:

Frontiers in Cell & Developmental Biology, 2024, p. 1, doi. 10.3389/fcell.2023.1324898

By:

Yoshiro Nakahara;
Taku Kouro;
Satoru Motoyama;
Masatomo Miura;
Kazuma Fujita;
Yuka Igarashi;
Naoko Higashijima;
Norikazu Matsuo;
Hidetomo Himuro;
Feifei Wei;
Shun Horaguchi;
Kayoko Tsuji;
Yasunobu Mano;
Mitsuru Komahashi;
Haruhiro Saito;
Koichi Azuma;
Tetsuro Sasada

Publication type:

Article

Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

Published in:

Biomedicines, 2024, v. 12, n. 8, p. 1831, doi. 10.3390/biomedicines12081831

By:

Horaguchi, Shun;
Nakahara, Yoshiro;
Igarashi, Yuka;
Kouro, Taku;
Wei, Feifei;
Murotani, Kenta;
Udagawa, Seiichi;
Higashijima, Naoko;
Matsuo, Norikazu;
Murakami, Shuji;
Kato, Terufumi;
Kondo, Tetsuro;
Xiang, Huihui;
Kasajima, Rika;
Himuro, Hidetomo;
Tsuji, Kayoko;
Mano, Yasunobu;
Komahashi, Mitsuru;
Miyagi, Yohei;
Saito, Haruhiro

Publication type:

Article

Pneumothorax during Pemetrexed Treatment in a Patient with Non-Small Cell Lung Cancer: A Case Report and Literature Review.

Published in:

2017

By:

Nakahara, Yoshiro;
Mikura, Shinichiro;
Nagamata, Makoto;
Fukui, Tomoya;
Sasaki, Jiichiro;
Masuda, Noriyuki

Publication type:

Case Study

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.

Published in:

International Journal of Clinical Oncology, 2022, v. 27, n. 4, p. 695, doi. 10.1007/s10147-022-02120-0

By:

John, Thomas;
Sakai, Hiroshi;
Ikeda, Satoshi;
Cheng, Ying;
Kasahara, Kazuo;
Sato, Yuki;
Nakahara, Yoshiro;
Takeda, Masayuki;
Kaneda, Hiroyasu;
Zhang, Helong;
Maemondo, Makoto;
Minato, Koichi;
Hisada, Takeshi;
Misumi, Yuki;
Satouchi, Miyako;
Hotta, Katsuyuki;
Li, Ang;
Oukessou, Abderrahim;
Lu, Shun

Publication type:

Article

Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations.

Published in:

Oncology Research & Treatment, 2017, v. 40, n. 1/2, p. 7, doi. 10.1159/000455147

By:

Satoshi Igawa;
Shiichiro Ryuge;
Masaaki Ichinoe;
Hiroyasu Nakashima;
Sakiko Otani;
Yoshiro Nakahara;
Tomoya Fukui;
Jiichiro Sasaki;
Masaru Kubota;
Masato Katagiri;
Yoshiki Murakumo;
Yukitoshi Satoh;
Yuichi Sato;
Noriyuki Masuda

Publication type:

Article

A case of lung adenocarcinoma with a novel CD74‐ROS1 fusion variant identified by comprehensive genomic profiling that responded to crizotinib and entrectinib.

Published in:

Thoracic Cancer, 2021, v. 12, n. 18, p. 2504, doi. 10.1111/1759-7714.14093

By:

Hashiguchi, Mizuha Haraguchi;
Sato, Takashi;
Watanabe, Rinako;
Kagyo, Junko;
Matsuzaki, Tomohiko;
Domoto, Hideharu;
Kato, Terufumi;
Nakahara, Yoshiro;
Yokose, Tomoyuki;
Hiroshima, Yukihiko;
Shiomi, Tetsuya

Publication type:

Article

Tumor invasion in the central airway is a risk factor for early‐onset checkpoint inhibitor pneumonitis in patients with non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2020, v. 11, n. 12, p. 3576, doi. 10.1111/1759-7714.13703

By:

Moda, Mitsuhiro;
Saito, Haruhiro;
Kato, Terufumi;
Usui, Ryo;
Kondo, Tetsuro;
Nakahara, Yoshiro;
Murakami, Shuji;
Yamamoto, Kouji;
Yamada, Kouzo

Publication type:

Article

Serum immune modulators during the first cycle of anti‐PD‐1 antibody therapy in non‐small cell lung cancer: Perforin as a biomarker.

Published in:

Thoracic Cancer, 2020, v. 11, n. 11, p. 3223, doi. 10.1111/1759-7714.13650

By:

Ota, Takayo;
Fukui, Tomoya;
Nakahara, Yoshiro;
Takeda, Takayuki;
Uchino, Junji;
Mouri, Takako;
Kudo, Keita;
Nakajima, Saki;
Suzumura, Tomohiro;
Fukuoka, Masahiro

Publication type:

Article

Questionnaire survey on patient awareness of invasive rebiopsy in advanced non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2019, v. 10, n. 3, p. 501, doi. 10.1111/1759-7714.12964

By:

Fukui, Tomoya;
Ishihara, Mikiko;
Kasajima, Masashi;
Hiyoshi, Yasuhiro;
Nakahara, Yoshiro;
Otani, Sakiko;
Igawa, Satoshi;
Yokoba, Masanori;
Mitsufuji, Hisashi;
Kubota, Masaru;
Katagiri, Masato;
Sasaki, Jiichiro;
Naoki, Katsuhiko

Publication type:

Article

Retrospective analysis of unknown primary cancers with malignant pleural effusion at initial diagnosis.

Published in:

Thoracic Cancer, 2016, v. 7, n. 1, p. 39, doi. 10.1111/1759-7714.12271

By:

Ebata, Takahiro;
Okuma, Yusuke;
Nakahara, Yoshiro;
Yomota, Makiko;
Takagi, Yusuke;
Hosomi, Yukio;
Asami, Eichi;
Omuro, Yasushi;
Hishima, Tsunekazu;
Okamura, Tatsuru;
Takiguchi, Yuichi

Publication type:

Article

A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer.

Published in:

Cancer Management & Research, 2021, v. 13, p. 8695, doi. 10.2147/CMAR.S339891

By:

Igawa, Satoshi;
Kasajima, Masashi;
Ono, Taihei;
Ozawa, Takahiro;
Kakegawa, Mikiko;
Kusuhara, Seiichiro;
Sato, Takashi;
Nakahara, Yoshiro;
Fukui, Tomoya;
Yokoba, Masanori;
Kubota, Masaru;
Mitsufuji, Hisashi;
Sasaki, Jiichiro;
Naoki, Katsuhiko

Publication type:

Article

Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease.

Published in:

Cancer Management & Research, 2018, v. 10, p. 7013, doi. 10.2147/CMAR.S189556

By:

Igawa, Satoshi;
Nishinarita, Noriko;
Takakura, Akira;
Ozawa, Takahiro;
Harada, Shinya;
Kusuhara, Seiichiro;
Niwa, Hideyuki;
Hosotani, Shinji;
Sone, Hideyuki;
Nakahara, Yoshiro;
Fukui, Tomoya;
Mitsufuji, Hisashi;
Yokoba, Masanori;
Kubota, Masaru;
Katagiri, Masato;
Sasaki, Jiichiro;
Naoki, Katsuhiko

Publication type:

Article

Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer.

Published in:

Cancer Management & Research, 2018, v. 10, p. 6039, doi. 10.2147/CMAR.S181789

By:

Shirasawa, Masayuki;
Fukui, Tomoya;
Kusuhara, Seiichiro;
Hiyoshi, Yasuhiro;
Ishihara, Mikiko;
Kasajima, Masashi;
Nakahara, Yoshiro;
Otani, Sakiko;
Igawa, Satoshi;
Yokoba, Masanori;
Mitsufuji, Hisashi;
Katagiri, Masato;
Sasaki, Jiichiro;
Naoki, Katsuhiko

Publication type:

Article

Prospective exosome-focused translational research for afatinib (EXTRA) study of patients with nonsmall cell lung cancer harboring EGFR mutation: an observational clinical study.

Published in:

Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231177021

By:

Takata, Saori;
Morikawa, Kei;
Tanaka, Hisashi;
Itani, Hidetoshi;
Ishihara, Masashi;
Horiuchi, Kazuya;
Kato, Yasuhiro;
Ikemura, Shinnosuke;
Nakagawa, Hideyuki;
Nakahara, Yoshiro;
Seki, Yoshitaka;
Bessho, Akihiro;
Takahashi, Nobumasa;
Hayashi, Kentaro;
Endo, Takeo;
Takeyama, Kiyoshi;
Maekura, Toshiya;
Takigawa, Nagio;
Kawase, Akikazu;
Endoh, Makoto

Publication type:

Article

Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia.

Published in:

2019

By:

Shirasawa, Masayuki;
Fukui, Tomoya;
Kusuhara, Seiichiro;
Hiyoshi, Yasuhiro;
Nakahara, Yoshiro;
Nishinarita, Noriko;
Igawa, Satoshi;
Naoki, Katsuhiko

Publication type:

journal article

Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study.

Published in:

2019

By:

Fukui, Tomoya;
Okuma, Yuriko;
Nakahara, Yoshiro;
Otani, Sakiko;
Igawa, Satoshi;
Katagiri, Masato;
Mitsufuji, Hisashi;
Kubota, Masaru;
Hiyoshi, Yasuhiro;
Ishihara, Mikiko;
Kasajima, Masashi;
Sasaki, Jiichiro;
Naoki, Katsuhiko

Publication type:

journal article

Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: Thoracic Oncology Research Group (TORG) 1017.

Published in:

Molecular & Clinical Oncology, 2019, v. 11, n. 4, p. 349, doi. 10.3892/mco.2019.1903

By:

Nakahara, Yoshiro;
Hosomi, Yukio;
Shibuya, Masahiko;
Mitsufuji, Hisashi;
Katagiri, Masato;
Naoki, Katsuhiko;
Soejima, Kenzo;
Nogami, Naoyuki;
Nagase, Seisuke;
Nishikawa, Masanori;
Minato, Koichi;
Takiguchi, Yuichi;
Seki, Nobuhiko;
Yamada, Kouzo;
Seto, Takashi;
Okamoto, Hiroaki

Publication type:

Article

Safety and efficacy of carboplatin plus nab-paclitaxel for treating advanced non-small-cell lung cancer with interstitial lung disease.

Published in:

Molecular & Clinical Oncology, 2017, v. 7, n. 4, p. 604, doi. 10.3892/mco.2017.1359

By:

HIDEYUKI NIWA;
YOSHIRO NAKAHARA;
MASANORI YOKOBA;
HISASHI MITSUFUJI;
JIICHIRO SASAKI;
NORIYUKI MASUDA

Publication type:

Article

Interstitial pneumonia following administration of pegfilgrastim during carboplatin and etoposide chemotherapy for small-cell lung cancer.

Published in:

2016

By:

MASAYUKI SHIRASAWA;
YOSHIRO NAKAHARA;
HIDEYUKI NIWA;
SHINYA HARADA;
TAKAHIRO OZAWA;
SEIICHIRO KUSUHARA;
MASASHI KASAJIMA;
YASUHIRO HIYOSHI;
JIICHIRO SASAKI;
NORIYUKI MASUDA

Publication type:

Case Study

Predictive significance of thyroid transcription factor-1 expression in patients with non-squamous non-small cell lung cancer with wild-type epidermal growth factor receptor treated with erlotinib.

Published in:

Molecular & Clinical Oncology, 2016, v. 5, n. 1, p. 14, doi. 10.3892/mco.2016.870

By:

YOSHIRO NAKAHARA;
YUKIO HOSOMI;
MAKOTO SAITO;
MASUMI OGAWA;
TSUNEKAZU HISHIMA;
TATSURU OKAMURA;
JIICHIRO SASAKI;
NORIYUKI MASUDA

Publication type:

Article

Neurotoxicity due to prophylactic cranial irradiation for small-cell lung cancer: A retrospective analysis.

Published in:

Molecular & Clinical Oncology, 2015, v. 3, n. 5, p. 1048, doi. 10.3892/mco.2015.581

By:

YOSHIRO NAKAHARA;
YUSUKE TAKAGI;
YUSUKE OKUMA;
YUKIO HOSOMI;
TATSURU OKAMURA;
MASAHIKO SHIBUYA;
NORIYUKI MASUDA

Publication type:

Article

A phase II study of nanoparticle albumin-bound paclitaxel plus carboplatin as the first-line therapy in elderly patients with previously untreated advanced non-small cell lung cancer.

Published in:

2016

By:

Okuma, Yusuke;
Hosomi, Yukio;
Takahashi, Satoshi;
Nakahara, Yoshiro;
Watanabe, Kageaki;
Nagamata, Makoto;
Takagi, Yusuke;
Mikura, Shinichiro

Publication type:

journal article

Phase II study of oral vitamin B12 supplementation as an alternative to intramuscular injection for patients with non-small cell lung cancer undergoing pemetrexed therapy.

Published in:

2016

By:

Takagi, Yusuke;
Hosomi, Yukio;
Nagamata, Makoto;
Watanabe, Kageaki;
Takahashi, Satoshi;
Nakahara, Yoshiro;
Yomota, Makiko;
Sunami, Kuniko;
Okuma, Yusuke;
Shimokawa, Tsuneo;
Okamura, Tatsuru

Publication type:

journal article

The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors.

Published in:

Oncology, 2023, v. 101, n. 11, p. 685, doi. 10.1159/000530809

By:

Akazawa, Yuki;
Igawa, Satoshi;
Yamada, Kaori;
Yamamoto, Hiroki;
Yagami, Yuri;
Kaizuka, Nobuki;
Manaka, Hiroya;
Kasajima, Masashi;
Nakahara, Yoshiro;
Sato, Takashi;
Mitsufuji, Hisashi;
Yokoba, Masanori;
Kubota, Masaru;
Sasaki, Jiichiro;
Naoki, Katsuhiko

Publication type:

Article

The Glasgow Prognostic Score Predicts Survival Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer.

Published in:

Oncology, 2023, v. 101, n. 11, p. 695, doi. 10.1159/000532087

By:

Igawa, Satoshi;
Yamamoto, Hiroki;
Yamada, Kaori;
Akazawa, Yuki;
Manaka, Hiroya;
Yagami, Yuri;
Nakahara, Yoshiro;
Sato, Takashi;
Mitsufuji, Hisashi;
Sasaki, Jiichiro;
Naoki, Katsuhiko

Publication type:

Article

The Glasgow Prognostic Score Predicts Outcomes of Pembrolizumab or Atezolizumab Monotherapy in Patients with Pretreated Non-Small Cell Lung Cancer.

Published in:

Oncology, 2023, v. 101, n. 1, p. 69, doi. 10.1159/000526964

By:

Kasajima, Masashi;
Igawa, Satoshi;
Manaka, Hiroya;
Yamada, Kaori;
Akazawa, Yuki;
Manabe, Hideaki;
Yagami, Yuri;
Yamamoto, Hiroki;
Ito, Hiroki;
Kaizuka, Nobuki;
Nakahara, Yoshiro;
Sato, Takashi;
Mitshufuji, Hisashi;
Yokoba, Masanori;
Kubota, Masaru;
Sasaki, Jiichiro;
Naoki, Katsuhiko

Publication type:

Article

Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma.

Published in:

Cancer Medicine, 2020, v. 9, n. 20, p. 7418, doi. 10.1002/cam4.3385

By:

Okuma, Yusuke;
Goto, Yasushi;
Ohyanagi, Fumiyoshi;
Sunami, Kuniko;
Nakahara, Yoshiro;
Kitazono, Satoru;
Kudo, Keita;
Tambo, Yuichi;
Kanda, Shintaro;
Yanagitani, Noriko;
Horiike, Atsushi;
Horinouchi, Hidehito;
Fujiwara, Yutaka;
Nokihara, Hiroshi;
Yamamoto, Noboru;
Nishio, Makoto;
Ohe, Yuichiro;
Hosomi, Yukio

Publication type:

Article

Promising Response to Dabrafenib Plus Trametinib in a Patient with Peritoneal Carcinomatosis from Non Small Lung Cancer Harboring BRAF V600E Mutation.

Published in:

OncoTargets & Therapy, 2022, v. 15, p. 1369, doi. 10.2147/OTT.S375246

By:

Yagami, Yuri;
Nakahara, Yoshiro;
Manabe, Hideaki;
Yamamoto, Hiroki;
Otani, Sakiko;
Sato, Takashi;
Igawa, Satoshi;
Kubota, Masaru;
Sasaki, Jiichiro;
Naoki, Katsuhiko

Publication type:

Article

Pulmonary amyloidosis mimicking prostate cancer metastasis.

Published in:

Clinical Case Reports, 2015, v. 3, n. 7, p. 626, doi. 10.1002/ccr3.282

By:

Natsume, Soichiro;
Nakahara, Yoshiro;
Okamura, Tatsuru;
Hishima, Tsunekazu

Publication type:

Article

Multi-omics analysis-based clinical and functional significance of a novel prognostic and immunotherapeutic gene signature derived from amino acid metabolism pathways in lung adenocarcinoma.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1361992

By:

Xiang, Huihui;
Kasajima, Rika;
Azuma, Koichi;
Tagami, Tomoyuki;
Hagiwara, Asami;
Nakahara, Yoshiro;
Saito, Haruhiro;
Igarashi, Yuka;
Wei, Feifei;
Ban, Tatsuma;
Yoshihara, Mitsuyo;
Nakamura, Yoshiyasu;
Sato, Shinya;
Koizume, Shiro;
Tamura, Tomohiko;
Sasada, Tetsuro;
Miyagi, Yohei

Publication type:

Article

Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non‐small‐Cell Lung Cancer in Patients Aged 75 Years and Older.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1042, doi. 10.1002/cpt.3339

By:

Yagishita, Shigehiro;
Yamanaka, Yuta;
Kurata, Takayasu;
Watanabe, Kageaki;
Hosomi, Yukio;
Horinouchi, Hidehito;
Ohe, Yuichiro;
Nakahara, Yoshiro;
Naoki, Katsuhiko;
Asao, Tetsuhiko;
Takahashi, Kazuhisa;
Saeki, Sho;
Sakagami, Takuro;
Nakashima, Kazuhisa;
Tsubata, Yukari;
Fujita, Yu;
Wakui, Hiroshi;
Furuta, Megumi;
Konishi, Jun Sakakibara;
Ohuchi, Mayu

Publication type:

Article

Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2829, doi. 10.1007/s00262-023-03464-w

By:

Himuro, Hidetomo;
Nakahara, Yoshiro;
Igarashi, Yuka;
Kouro, Taku;
Higashijima, Naoko;
Matsuo, Norikazu;
Murakami, Shuji;
Wei, Feifei;
Horaguchi, Shun;
Tsuji, Kayoko;
Mano, Yasunobu;
Saito, Haruhiro;
Azuma, Koichi;
Sasada, Tetsuro

Publication type:

Article

Clinical significance of peripheral TCR and BCR repertoire diversity in EGFR/ALK wild-type NSCLC treated with anti-PD-1 antibody.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 10, p. 2881, doi. 10.1007/s00262-021-02900-z

By:

Nakahara, Yoshiro;
Matsutani, Takaji;
Igarashi, Yuka;
Matsuo, Norikazu;
Himuro, Hidetomo;
Saito, Haruhiro;
Yamada, Kouzo;
Murotani, Kenta;
Hoshino, Tomoaki;
Azuma, Koichi;
Sasada, Tetsuro

Publication type:

Article

Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 5287, doi. 10.2147/OTT.S105976

By:

Yoshiro Nakahara;
Yusuke Takagi;
Yukio Hosomi;
Akiko Kagei;
Tomohiro Yamamoto;
Takeshi Sawada;
Makiko Yomota;
Yusuke Okuma;
Shinichiro Mikura;
Tatsuru Okamura

Publication type:

Article

Eligibility for Bevacizumab as an Independent Prognostic Factor for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study.

Published in:

PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0059700

By:

Takagi, Yusuke;
Toriihara, Akira;
Nakahara, Yoshiro;
Yomota, Makiko;
Okuma, Yusuke;
Hosomi, Yukio;
Shibuya, Masahiko;
Okamura, Tatsuru

Publication type:

Article

Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016.

Published in:

2018

By:

Ikeda, Satoshi;
Kato, Terufumi;
Ogura, Takashi;
Sekine, Akimasa;
Oda, Tsuneyuki;
Masuda, Noriyuki;
Igawa, Satoshi;
Katono, Ken;
Otani, Sakiko;
Yamada, Kouzo;
Saito, Haruhiro;
Kondo, Tetsuro;
Hosomi, Yukio;
Nakahara, Yoshiro;
Nishikawa, Masanori;
Utumi, Keiko;
Misumi, Yuki;
Yamanaka, Takeharu;
Sakamaki, Kentaro;
Okamoto, Hiroaki

Publication type:

journal article

Symptom Management and Supportive Care. A Prospective Study of Shortened Vitamin Supplementation Prior to Cisplatin-Pemetrexed Therapy for Non-Small Cell Lung Cancer.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1193, doi. 10.1634/theoncologist.2014-0221

By:

Takagi, Yusuke;
Hosomi, Yukio;
Sunami, Kuniko;
Nakahara, Yoshiro;
Okuma, Yusuke;
Yomota, Makiko;
Shimokawa, Tsuneo;
Nagamata, Makoto;
Iguchi, Mari;
Okamoto, Hiroaki;
Okamura, Tatsuru;
Shibuya, Masahiko

Publication type:

Article

Suitability of Bronchoscopic Biopsy Tissue Samples for Next-Generation Sequencing.

Published in:

Diagnostics (2075-4418), 2021, v. 11, n. 3, p. 391, doi. 10.3390/diagnostics11030391

By:

Murakami, Shuji;
Yokose, Tomoyuki;
Nemoto, Daiji;
Suzuki, Masaki;
Usui, Ryou;
Nakahara, Yoshiro;
Kondo, Tetsuro;
Kato, Terufumi;
Saito, Haruhiro;
Ragazzi, Moira

Publication type:

Article

Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma.

Published in:

Investigational New Drugs, 2023, v. 41, n. 1, p. 115, doi. 10.1007/s10637-023-01327-w

By:

Manaka, Hiroya;
Igawa, Satoshi;
Yamamoto, Michiko;
Oguri, Akito;
Manabe, Hideaki;
Kasajima, Masashi;
Kusuhara, Seiichiro;
Hosotani, Shinji;
Nakahara, Yoshiro;
Sato, Takashi;
Fukui, Tomoya;
Hisashi, Mitsufuji;
Sasaki, Jiichiro;
Naoki, Katsuhiko

Publication type:

Article

First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational study.

Published in:

Investigational New Drugs, 2022, v. 40, n. 2, p. 430, doi. 10.1007/s10637-021-01195-2

By:

Igawa, Satoshi;
Fukui, Tomoya;
Kasajima, Masashi;
Ono, Taihei;
Ozawa, Takahiro;
Kakegawa, Mikiko;
Kusuhara, Seiichiro;
Sato, Takashi;
Nakahara, Yoshiro;
Hisashi, Mitsufuji;
Sasaki, Jiichiro;
Naoki, Katsuhiko

Publication type:

Article

Real-world evaluation of second line chemotherapy for patients with advanced non-small cell lung cancer harboring preexisting interstitial lung disease.

Published in:

Investigational New Drugs, 2022, v. 40, n. 1, p. 182, doi. 10.1007/s10637-021-01162-x

By:

Igawa, Satoshi;
Yokoba, Masanori;
Takakura, Akira;
Hosotani, Shinji;
Nakahara, Yoshiro;
Sato, Takashi;
Mitsufuji, Hisashi;
Sasaki, Jiichiro;
Naoki, Katsuhiko

Publication type:

Article

Phase II study of amrubicin plus erlotinib in previously treated, advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (TORG1320).

Published in:

Investigational New Drugs, 2021, v. 39, n. 2, p. 530, doi. 10.1007/s10637-020-01031-z

By:

Otani, Sakiko;
Sasaki, Jiichiro;
Nakahara, Yoshiro;
Fukui, Tomoya;
Igawa, Satoshi;
Naoki, Katsuhiko;
Bessho, Akihiro;
Hosokawa, Shinobu;
Fukamatsu, Nobuaki;
Nakamura, Yukiko;
Kasai, Takashi;
Sugiyama, Tomohide;
Tokito, Takaaki;
Seki, Nobuhiko;
Hamada, Akinobu;
Okamoto, Hiroaki;
Masuda, Noriyuki

Publication type:

Article

Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913.

Published in:

Investigational New Drugs, 2021, v. 39, n. 1, p. 202, doi. 10.1007/s10637-020-00985-4

By:

Nakahara, Yoshiro;
Shimokawa, Tsuneo;
Misumi, Yuki;
Nogami, Naoyuki;
Shinkai, Tetsu;
Seki, Nobuhiko;
Hosomi, Yukio;
Hida, Naoya;
Okamoto, Hiroaki

Publication type:

Article

Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non–small cell lung cancer.

Published in:

Investigational New Drugs, 2018, v. 36, n. 1, p. 45, doi. 10.1007/s10637-017-0472-x

By:

Igawa, Satoshi;
Otani, Sakiko;
Nakahara, Yoshiro;
Ryuge, Shinichiro;
Hiyoshi, Yasuhiro;
Fukui, Tomoya;
Mitsufuji, Hisashi;
Kubota, Masaru;
Katagiri, Masato;
Sato, Yuichi;
Sasaki, Jiichiro;
Masuda, Noriyuki

Publication type:

Article

Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer.

Published in:

Investigational New Drugs, 2017, v. 35, n. 5, p. 642, doi. 10.1007/s10637-017-0482-8

By:

Igawa, Satoshi;
Otani, Sakiko;
Ryuge, Shinichiro;
Fukui, Tomoya;
Nakahara, Yoshiro;
Hiyoshi, Yasuhiro;
Ishihara, Mikiko;
Kusuhara, Seiichiro;
Harada, Shinya;
Mitsufuji, Hisashi;
Kubota, Masaru;
Sasaki, Jiichiro;
Masuda, Noriyuki

Publication type:

Article